MX2018015607A - Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad. - Google Patents
Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad.Info
- Publication number
- MX2018015607A MX2018015607A MX2018015607A MX2018015607A MX2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A
- Authority
- MX
- Mexico
- Prior art keywords
- microstructure
- skin
- present
- hyaluronic acid
- solubility characteristics
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 3
- 229920002674 hyaluronan Polymers 0.000 abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 abstract 3
- 239000004615 ingredient Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Neurosurgery (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Biological Depolymerization Polymers (AREA)
Abstract
La presente invención se refiere a una microestructura de ácido hialurónico que tiene excelentes características de solubilidad. Más específicamente, la presente invención se refiere a una microestructura biodegradable que comprende ácido hialurónico reticulado y que tiene excelentes características de solubilidad durante la penetración en la piel. Cuando la microestructura de la presente invención es penetrada en la piel, las características de solubilidad en la piel son excelentes, la velocidad de disolución en la piel se puede controlar fácilmente de acuerdo con la relación de contenido del ácido hialurónico reticulado, y, mientras que los ingredientes efectivos proporcionados en la microestructura se pueden administrar de manera estable en la piel, la velocidad de liberación de los ingredientes efectivos proporcionados se puede controlar fácilmente y, por lo tanto, la presente invención se puede usar como un sistema de suministro transdérmico para materiales farmacológicamente activos o materiales para mejorar la piel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160074985 | 2016-06-16 | ||
| PCT/KR2017/006342 WO2017217818A1 (ko) | 2016-06-16 | 2017-06-16 | 용해 특성이 우수한 히알루론산 마이크로구조체 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018015607A true MX2018015607A (es) | 2019-03-14 |
| MX385220B MX385220B (es) | 2025-03-13 |
Family
ID=60663275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018015607A MX385220B (es) | 2016-06-16 | 2017-06-16 | Microestructura de ácido hialurónico que tiene excelentes características de solubilidad. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11013670B2 (es) |
| EP (1) | EP3473242A4 (es) |
| JP (1) | JP6900405B2 (es) |
| KR (1) | KR101973801B1 (es) |
| CN (1) | CN109310625A (es) |
| MX (1) | MX385220B (es) |
| TW (2) | TWI718576B (es) |
| WO (1) | WO2017217818A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102025546B1 (ko) | 2017-11-22 | 2019-09-26 | 단국대학교 천안캠퍼스 산학협력단 | 히알루론산-칼슘 복합체 및 알지네이트를 포함하는 약물 전달체 |
| ES2989582T3 (es) | 2018-05-03 | 2024-11-27 | Collplant Ltd | Rellenos dérmicos y aplicaciones de los mismos |
| CN113382718B (zh) * | 2019-02-22 | 2023-05-26 | 生化学工业株式会社 | 保存性能提高方法 |
| KR102728107B1 (ko) * | 2019-08-08 | 2024-11-11 | (주)아모레퍼시픽 | 동결건조 제형 조성물 및 이를 포함하는 피부 외용제 화장품 키트 |
| TR201922945A2 (tr) * | 2019-12-31 | 2021-07-26 | Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi | Osteoartri̇t tedavi̇si̇ i̇çi̇n propoli̇s i̇çeri̇kli̇ yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇ |
| EP3854375A1 (en) * | 2020-01-23 | 2021-07-28 | Paean Aesthetics Inc | Micro-spicule composition to control its shape and method for producing the same |
| US11129788B1 (en) * | 2020-03-24 | 2021-09-28 | Elc Management Llc | Sprayable film forming compositions for improving the performance of topical preparations |
| KR102122208B1 (ko) * | 2020-04-07 | 2020-06-12 | 주식회사 라파스 | 마이크로니들 패치를 이용한 최소 침습적 아토피 피부염 검사 방법 및 마이크로니들 패치를 포함하는 최소 침습적 아토피 검사 키트 |
| FR3109153B1 (fr) * | 2020-04-10 | 2022-07-15 | Teoxane SA | Compositions à base d’au moins deux glycosaminoglycanes |
| JP2023523952A (ja) | 2020-04-28 | 2023-06-08 | ティコナ・エルエルシー | マイクロニードルアセンブリ |
| KR102740968B1 (ko) * | 2020-09-18 | 2024-12-11 | 강원대학교산학협력단 | 비타민c 유도체를 포함하는 피부미백 및 주름개선 이중기능성 마이크로니들, 이의 제조방법 및 이를 포함하는 경피전달용 패치 |
| US20250339365A1 (en) * | 2020-10-28 | 2025-11-06 | Fount Bio, Inc. | Transdermal delivery |
| KR102798205B1 (ko) * | 2021-08-12 | 2025-04-22 | 주식회사 페로카 | 마이크로니들 패치 |
| CN114311721B (zh) | 2021-12-27 | 2023-09-08 | 青岛农业大学 | 一种可食用、可生物降解餐具的制备方法 |
| KR102643334B1 (ko) * | 2022-08-23 | 2024-03-05 | 주식회사 큐에이치바이오 | 가교 히알루론산 및 생체 적합성 미립자를 포함하는 피부 필러 조성물, 및 그 제조방법 |
| WO2025174199A1 (ko) * | 2024-02-15 | 2025-08-21 | 주식회사 티앤엘 | 마이크로니들용 조성물 및 이를 이용한 마이크로니들 |
| KR20250161695A (ko) * | 2024-05-08 | 2025-11-18 | 정성희 | 광역학 치료용 용해성 마이크로니들 및 이의 제조방법 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7963997B2 (en) * | 2002-07-19 | 2011-06-21 | Kensey Nash Corporation | Device for regeneration of articular cartilage and other tissue |
| JP3420851B2 (ja) | 1994-12-06 | 2003-06-30 | 株式会社資生堂 | 癒着防止剤 |
| JP4210231B2 (ja) | 2004-03-25 | 2009-01-14 | 株式会社資生堂 | 皮膚のシワを改善する美容方法及びシワ改善具 |
| FR2909560B1 (fr) * | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
| JP5243560B2 (ja) * | 2008-02-27 | 2013-07-24 | ケーシーアイ ライセンシング インコーポレイテッド | 組織部位における創傷を治療するシステムおよび方法 |
| JP5267910B2 (ja) | 2008-02-28 | 2013-08-21 | コスメディ製薬株式会社 | マイクロニードルアレイ |
| WO2010040271A1 (en) | 2008-10-07 | 2010-04-15 | Tuo Jin | Phase-transition polymeric microneedles |
| WO2012008722A2 (ko) * | 2010-07-12 | 2012-01-19 | 신풍제약 주식회사 | 조직 증강용 충전 조성물 |
| US20140200508A1 (en) | 2012-06-29 | 2014-07-17 | Isaac D. Cohen | Microneedles Comprising One Or More Cosmetic Ingredients |
| CN110025881A (zh) | 2012-09-13 | 2019-07-19 | 亚夫拉罕·阿米尔 | 用于皮肤改善的递送装置和方法 |
| KR101435888B1 (ko) * | 2012-10-23 | 2014-09-01 | 연세대학교 산학협력단 | 히알루론산을 이용한 생분해성 마이크로니들 제조방법 |
| CN105073178B (zh) * | 2012-12-21 | 2019-07-30 | 考里安国际公司 | 用于治疗剂递送的微阵列及其使用方法 |
| CN104095761A (zh) * | 2013-04-08 | 2014-10-15 | 上海汇林医药科技有限公司 | 一种高分子聚合物微针贴剂及其应用 |
| JP6906885B2 (ja) * | 2014-11-14 | 2021-07-21 | ロレアル | しわを減少させるためのマイクロニードルシート |
| US10493160B2 (en) * | 2015-02-13 | 2019-12-03 | Endoderma Co., Ltd. | Microstructure using cross-linked hyaluronic acid hydrogel, and method for producing same |
| CN104921961B (zh) | 2015-05-25 | 2017-11-17 | 成都凤磐生物科技有限公司 | 一种多效修复的可降解生物微针贴 |
| MX395329B (es) | 2015-12-28 | 2025-03-25 | Endoderma Co Ltd | Microestructura para absorción transdérmica y método para la fabricación del mismo. |
-
2017
- 2017-06-16 WO PCT/KR2017/006342 patent/WO2017217818A1/ko not_active Ceased
- 2017-06-16 KR KR1020170076877A patent/KR101973801B1/ko active Active
- 2017-06-16 EP EP17813641.2A patent/EP3473242A4/en not_active Withdrawn
- 2017-06-16 TW TW108122646A patent/TWI718576B/zh active
- 2017-06-16 JP JP2018565661A patent/JP6900405B2/ja active Active
- 2017-06-16 US US16/310,488 patent/US11013670B2/en active Active
- 2017-06-16 TW TW106120234A patent/TWI675666B/zh active
- 2017-06-16 MX MX2018015607A patent/MX385220B/es unknown
- 2017-06-16 CN CN201780037595.XA patent/CN109310625A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR101973801B1 (ko) | 2019-04-30 |
| JP6900405B2 (ja) | 2021-07-07 |
| TW201938175A (zh) | 2019-10-01 |
| US11013670B2 (en) | 2021-05-25 |
| TWI718576B (zh) | 2021-02-11 |
| KR20170142127A (ko) | 2017-12-27 |
| WO2017217818A1 (ko) | 2017-12-21 |
| US20190336411A1 (en) | 2019-11-07 |
| EP3473242A4 (en) | 2019-06-19 |
| BR112018075703A2 (pt) | 2019-04-02 |
| TWI675666B (zh) | 2019-11-01 |
| TW201808310A (zh) | 2018-03-16 |
| JP2019523680A (ja) | 2019-08-29 |
| MX385220B (es) | 2025-03-13 |
| EP3473242A1 (en) | 2019-04-24 |
| CN109310625A (zh) | 2019-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018015607A (es) | Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad. | |
| CY1124380T1 (el) | Συστηματα διαβλεννογονιας και διαδερμικης χορηγησης | |
| MX2021001118A (es) | Composiciones que comprenden fibras obtenidas electrohidrodinamicamente para la administracion de dosificaciones especificas de una sustancia activa a piel o mucosa. | |
| CL2018001152A1 (es) | Composiciones y métodos para el tratamiento del cáncer | |
| CO2017004715A2 (es) | Métodos y formulaciones para tratar enfermedades vasculares de los ojos | |
| MX379786B (es) | Apósito para heridas o para la piel. | |
| CL2017001718A1 (es) | Derivados de glucagón con estabilidad mejorada | |
| CR20170361A (es) | Forma de dosificación que incluye una solución sólida de drogas amorfas | |
| UY37341A (es) | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada | |
| MX2018001499A (es) | Sistema para la entrega de polimeros liquidos para la administracion prolongada de farmacos. | |
| CL2016002753A1 (es) | Composición conservante de la madera | |
| MX2017006653A (es) | Metodos para modular los niveles de fármaco en plasma mediante el uso de eritrohidroxibupropión. | |
| MX384264B (es) | Material anisotropico biocompuesto, implantes medicos que lo comprenden y metodos para el tratamiento del mismo | |
| MX2018000166A (es) | Metodos para una mejor administración de agentes activos a tumores. | |
| CU20170099A7 (es) | Terapias de combinación para el tratamiento de cánceres | |
| CO2018009563A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue | |
| MX2017003623A (es) | Parche de opipramol. | |
| MX2022014634A (es) | Metodos para la administracion linfatica de agentes activos. | |
| CL2017000120A1 (es) | Composiciones en suspensión de ciclosporina a para inyecciones subconjuntivales y perioculares | |
| MX2022008203A (es) | Tratamiento de trastornos cutaneos. | |
| MX2014011855A (es) | Sistemas y metodos para tratar una respuesta farmacodinamica adversa inducida por opioides. | |
| MX2017015292A (es) | Composicion para tratar lesiones cerebrales. | |
| AR094289A1 (es) | Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol | |
| MX2021002633A (es) | Dispersiones solidas de bendamustina e infusion continua. | |
| UY36202A (es) | Composición farmacéutica que comprende hemoglobina recombinante o un agente terapéutico basado en subunidades para el tratamiento de cáncer |